- Service Name
Apellis Pharmaceuticals
- Industry
Biopharmaceutical, healthcare, therapeutics, chronic inflammatory diseases
- Main Value Proposition
Apellis aims to transform treatment for debilitating diseases through innovative therapies that address the underlying causes of these conditions.
- Description
Apellis Pharmaceuticals is a global biopharmaceutical company that develops life-changing therapies targeting diseases driven by excessive activation of the complement cascade. The company focuses on pioneering targeted C3 therapies in areas such as hematology, ophthalmology, and nephrology.
- Key Features
Pioneering targeted C3 therapies; Focus on chronic inflammatory diseases; Commitment to patient community engagement; Rapid innovation with two approvals in less than two years
- Use Cases
The service is most valuable in treating patients with chronic inflammatory diseases, particularly those affected by conditions related to the complement cascade, such as certain ophthalmological and hematological disorders.
- Competitive advantages
Strong focus on patient-centered care and community involvement; Rapid development and approval of innovative therapies; Expertise in complement biology, leading to unique treatment options
- Strengths
Apellis's main strengths include its innovative approach to drug development, a strong pipeline of therapies, and a commitment to addressing unmet medical needs in chronic inflammatory diseases.
- Positioning
Apellis positions itself as a leader in complement science, dedicated to developing therapies that significantly improve patient outcomes in chronic diseases.
- Audience
The target users include patients suffering from chronic inflammatory diseases, healthcare providers looking for innovative treatment options, and investors interested in biopharmaceutical advancements.
- CTA
Join our team
- Tags
biopharmaceuticals
chronic diseases
complement science
innovative therapies
- Tagline
Courageous Science + Compassion
- Tone of Voice
Innovative, compassionate, determined
- Differentiation
Apellis stands out in the biopharmaceutical market by focusing specifically on complement science and developing targeted therapies that address chronic inflammatory diseases, which are often overlooked by other companies.
- Brand Positioning
The brand identity of Apellis emphasizes innovation, compassion, and a commitment to patient advocacy, reflecting its mission to transform lives through science.
- Founded
2008-01-01
- Founders
Cedric Francois
Pascal Deschatelets